Definium Therapeutics grants 88,900 inducement stock options to new hires
DFTX•Inducement stock options issued to three new employees
Definium Therapeutics issued inducement stock options for 88,900 common shares to three newly hired non-executive employees.
The grants carry an effective date of Aug. 31, 2026, with an exercise price set at the stock’s closing price that day.
The vesting schedule spans four years: 25% after one year, with the remaining 75% vesting in substantially equal monthly installments over the next three years.
The awards were issued under the company’s 2026 Inducement Plan.
